Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no...

Area of Science:

• Critical Care Medicine
• Pathophysiology
• Clinical Trials

Background:

• Multiple organ failure (MOF) concept originated in the 1970s.
• Advancements in intensive care unit (ICU) support allowed prolonged patient survival, revealing MOF development.
• High MOF mortality rates spurred research into its underlying causes and treatments.

Purpose of the Study:

• To analyze the reasons behind the limited success of clinical trials for sepsis treatments.
• To propose a revised approach for clinical trial design in critical care.

Main Methods:

• Review of historical development of MOF concept.
• Analysis of clinical trial outcomes for sepsis and inflammation.
• Critique of entry criteria used in past sepsis trials.

Main Results:

• Clinical trials for sepsis treatments, despite promising preclinical data, have yielded limited or negative results.
• A significant factor contributing to trial failures is the use of broad patient entry criteria.
• The efficacy of treatments may be masked by heterogeneity in patient conditions and underlying pathologies.

Conclusions:

• Current clinical trials for sepsis often fail due to non-specific patient selection.
• Future trials should focus on specific diseases or injuries contributing to MOF rather than general sepsis.
• Tailoring treatments to specific pathophysiological states is crucial for improving outcomes in critically ill patients.